Volume 29, No 4, Apr 2019

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 29 Issue 4, April 2019: 337-337

CORRIGENDA

Author Correction: Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors

Jie Zhu ^1,2, Chang Ming ³, Xin Fu ^1,2, Yaou Duan ², Duc Anh Hoang ³, Jeffrey Rutgard ², Runze Zhang ², Wenqiu Wang ², Rui Hou ⁴,Daniel Zhang ², Edward Zhang ², Charlotte Zhang ² Eye Gene Therapy Consortium, Xiaoke Hao ⁵, Wenjun Xiong ³ and Kang Zhang ^1,2,6

¹ Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, 510623 Guangzhou, China; ²Shiley Eye Institute, Institute for Engineering in Medicine, Center for Genetic Therapy at Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA; ³Department of Biomedical Sciences, City University of HongKong, Hong Kong SAR, China; ⁴Guangzhou KangRui Biological Pharmaceutical Technology Company, 510005 Guangzhou, China; ⁵Department of Clinical Laboratory Medicine,
Xijing Hospital, Fourth Military Medical University, Xi’an 710032 Shanxi, China and ⁶Veterans Administration Healthcare System, San Diego, CA 92037, USA
These authors contributed equally: Jie Zhu, Chang Ming, Xin Fu Correspondence: Xiaoke Hao (haoxkg@fmmu.edu.cn) or Wenjun Xiong (wenjun.xiong@cityu.edu.hk) or Kang Zhang (kang.zhang@gmail.com)

Correction to: Cell Research (2017) 27:830–833; https://doi.org/10.1038/cr.2017.57; published online 21 April 2017.

https://doi.org/10.1038/s41422-019-0140-0

FULL TEXT | PDF

Browse 865